Vitamin D for bronchiectasis patients
Treatments studied
Part of Lungs & breathing clinical trials.
This trial tests if taking vitamin D can help people with bronchiectasis have fewer flare-ups. It is only for patients who were in an earlier study that checked their vitamin D levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years or older
- Diagnosed with bronchiectasis (not from cystic fibrosis) confirmed by a CT scan
- Took part in the earlier vitamin D study (UW 22-317) at Queen Mary Hospital
- No asthma, COPD, or other chronic lung disease
- No osteoporosis
- Not already taking vitamin D supplements
- No advanced kidney disease (eGFR less than 30)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a new drug, GSK3862995B, is safe and effective for adults with bronchiectasis. It might help reduce lung infections and improve symptoms.
This trial tests an inhaled medication for people with bronchiectasis, a lung condition causing chronic cough and mucus. It first checks safety in healthy volunteers, then studies how the drug works in people with bronchiectasis.
This trial tests whether a new medication, BI 1291583, can help people with bronchiectasis reduce lung infections and symptoms. You may join if you have had at least one or two lung flare-ups in the past year.
This study helps doctors understand how severe your bronchiectasis is and predict when you might have flare-ups. You'll have routine tests over 12 months to help researchers learn more about this condition and improve future care.
This study looks at how nutrition affects the course of bronchiectasis, a lung condition that causes coughing and frequent infections. It may help find ways to slow the disease down.
This study tests whether a common antibiotic called azithromycin can help prevent flare-ups (sudden worsening) of bronchiectasis—a lung condition where airways become permanently enlarged and damaged. Patients will take azithromycin or a placebo for 12 months to see if it reduces how often they get sick.
Hear when a new Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.